title: Varenicline for smoking reduction prior to cessation--reply.
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: Jon O
authors.initials: JO
authors.lastname: Ebbert
authors.affiliation: Department of Psychiatry, University of Vermont, Burlington.
authors.forename: John R
authors.initials: JR
authors.lastname: Hughes
authors.affiliation: Health Behaviour Research Centre, University College London, London, England.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: West
mesh_terms: D001552:Benzazepines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D011810:Quinoxalines / Q000627:therapeutic use*; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000188:drug therapy*
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines